Búsqueda | BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas

1.

Derivatives of amsacrine: determinants required for high activity against Lewis lung carcinoma.

Baguley, B C; Finlay, G J.

J Natl Cancer Inst ; 80(3): 195-9, 1988 Apr 06.

Artículo en Inglés | MEDLINE | ID: mdl-3346911

2.

Effect of flavone acetic acid on Lewis lung carcinoma: evidence for an indirect effect.

Finlay, G J; Smith, G P; Fray, L M; Baguley, B C.

J Natl Cancer Inst ; 80(4): 241-5, 1988 Apr 20.

Artículo en Inglés | MEDLINE | ID: mdl-3351960

3.

Blood flow failure as a major determinant in the antitumor action of flavone acetic acid.

Zwi, L J; Baguley, B C; Gavin, J B; Wilson, W R.

J Natl Cancer Inst ; 81(13): 1005-13, 1989 Jul 05.

Artículo en Inglés | MEDLINE | ID: mdl-2733044

4.

Experimental antitumor activity of the amsacrine analogue CI-921.

Leopold, W R; Corbett, T H; Griswold, D P; Plowman, J; Baguley, B C.

J Natl Cancer Inst ; 79(2): 343-9, 1987 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-3474465

5.

Evidence for the production of nitric oxide by activated macrophages treated with the antitumor agents flavone-8-acetic acid and xanthenone-4-acetic acid.

Thomsen, L L; Ching, L M; Baguley, B C.

Cancer Res ; 50(21): 6966-70, 1990 Nov 01.

Artículo en Inglés | MEDLINE | ID: mdl-2170013

6.

Tumor-dependent increased plasma nitrate concentrations as an indication of the antitumor effect of flavone-8-acetic acid and analogues in mice.

Thomsen, L L; Ching, L M; Zhuang, L; Gavin, J B; Baguley, B C.

Cancer Res ; 51(1): 77-81, 1991 Jan 01.

Artículo en Inglés | MEDLINE | ID: mdl-1988109

7.

Synthesis, antitumor activity, and DNA binding properties of a new derivative of amsacrine, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino) phenylamino]-4-acridinecarboxamide.

Baguley, B C; Denny, W A; Atwell, G J; Finlay, G J; Rewcastle, G W; Twigden, S J; Wilson, W R.

Cancer Res ; 44(8): 3245-51, 1984 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-6547635

8.

Cytokine induction and therapeutic synergy with interleukin-2 against murine renal and colon cancers by xanthenone-4-acetic acid derivatives.

Futami, H; Eader, L; Back, T T; Gruys, E; Young, H A; Wiltrout, R H; Baguley, B C.

J Immunother (1991) ; 12(4): 247-55, 1992 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-1477076

9.

Flavone acetic acid and 5,6-dimethylxanthenone-4-acetic acid: relationship between plasma nitrate elevation and the induction of tumour necrosis.

Veszelovszky, E; Thomsen, L L; Li, Z; Baguley, B C.

Eur J Cancer ; 29A(3): 404-8, 1993.

Artículo en Inglés | MEDLINE | ID: mdl-8398341

10.

In vitro methods for screening agents with an indirect mechanism of antitumour activity: xanthenone analogues of flavone acetic acid.

Ching, L M; Finlay, G J; Joseph, W R; Baguley, B C.

Eur J Cancer ; 27(12): 1684-9, 1991.

Artículo en Inglés | MEDLINE | ID: mdl-1782083

11.

Combining bioreductive drugs (SR 4233 or SN 23862) with the vasoactive agents flavone acetic acid or 5,6-dimethylxanthenone acetic acid.

Cliffe, S; Taylor, M L; Rutland, M; Baguley, B C; Hill, R P; Wilson, W R.

Int J Radiat Oncol Biol Phys ; 29(2): 373-7, 1994 May 15.

Artículo en Inglés | MEDLINE | ID: mdl-8195036

12.

Potential antitumor agents. 38. 3-substituted 5-carboxamido derivatives of amsacrine.

Denny, W A; Atwell, G J; Baguley, B C.

J Med Chem ; 26(11): 1619-25, 1983 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-6688829

13.

Potential antitumor agents. 39. Anilino ring geometry of amsacrine and derivatives: relationship to DNA binding and antitumor activity.

Denny, W A; Atwell, G J; Baguley, B C.

J Med Chem ; 26(11): 1625-30, 1983 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-6688830

14.

Potential antitumor agents. 44. Synthesis and antitumor activity of new classes of diacridines: importance of linker chain rigidity for DNA binding kinetics and biological activity.

Denny, W A; Atwell, G J; Baguley, B C; Wakelin, L P.

J Med Chem ; 28(11): 1568-74, 1985 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-4067986

15.

Potential antitumor agents. 60. Relationships between structure and in vivo colon 38 activity for 5-substituted 9-oxoxanthene-4-acetic acids.

Atwell, G J; Rewcastle, G W; Baguley, B C; Denny, W A.

J Med Chem ; 33(5): 1375-9, 1990 May.

Artículo en Inglés | MEDLINE | ID: mdl-2329557

16.

Nitric oxide production in endotoxin-resistant C3H/HeJ mice stimulated with flavone-8-acetic acid and xanthenone-4-acetic acid analogues.

Thomsen, L L; Ching, L M; Joseph, W R; Baguley, B C; Gavin, J B.

Biochem Pharmacol ; 43(11): 2401-6, 1992 Jun 09.

Artículo en Inglés | MEDLINE | ID: mdl-1610403

17.

Small-molecule cytokine inducers causing tumor necrosis.

Baguley, B C.

Curr Opin Investig Drugs ; 2(7): 967-75, 2001 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-11757800

18.

Serotonin involvement in the antitumour and host effects of flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid.

Baguley, B C; Cole, G; Thomsen, L L; Li, Z.

Cancer Chemother Pharmacol ; 33(1): 77-81, 1993.

Artículo en Inglés | MEDLINE | ID: mdl-8269593

19.

Nitric oxide: its production in host-cell-infiltrated EMT6 spheroids and its role in tumour cell killing by flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid.

Thomsen, L L; Baguley, B C; Wilson, W R.

Cancer Chemother Pharmacol ; 31(2): 151-5, 1992.

Artículo en Inglés | MEDLINE | ID: mdl-1451234

20.

Haematological effects in mice of the antitumour agents xanthenone-4-acetic acid, 5,6-dimethyl-xanthenone-4-acetic acid [correction of 5,6-methyl-] and flavone acetic acid.

Ching, L M; McKeage, M J; Joseph, W R; Kestell, P; Zwi, L J; Baguley, B C.

Cancer Chemother Pharmacol ; 28(6): 414-9, 1991.

Artículo en Inglés | MEDLINE | ID: mdl-1934245

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: